TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Angarns Bio AB
Closing information (x1000 EUR)
| Closing information | 2024/12 | 2023/12 | 2022/12 |
| Turnover |
216
|
279
|
239 |
| Financial expenses |
1
|
3
|
2 |
| Earnings before taxes |
149
|
252
|
218 |
| EBITDA |
153
|
261
|
228 |
| Total assets |
1,779
|
1,794
|
1,687 |
| Current assets |
213
|
235
|
112 |
| Current liabilities |
24
|
72
|
147 |
| Equity capital |
1,755
|
1,722
|
1,527 |
| - share capital |
9
|
9
|
9 |
| Employees (average) |
1
|
1
|
1 |
Financial ratios
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Solvency |
98.7%
|
96.0%
|
90.5% |
| Turnover per employee |
216
|
279
|
239 |
| Profit as a percentage of turnover |
69.0%
|
90.3%
|
91.2% |
| Return on assets (ROA) |
8.4%
|
14.2%
|
13.0% |
| Current ratio |
887.5%
|
326.4%
|
76.2% |
| Return on equity (ROE) |
8.5%
|
14.6%
|
14.3% |
| Change turnover |
-53
|
39
|
39 |
| Change turnover % |
-20%
|
16%
|
20% |
| Chg. No. of employees |
0
|
0
|
0 |
| Chg. No. of employees % |
0%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2024/12 | 2023/12 | 2022/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.